Abstract
Degenerative valvular heart disease, the most common form of valve disease in the Western world, can lead to aortic stenosis (AS) or mitral regurgitation (MR). In current guidelines for the management of patients with degenerative valvular disease, surgical intervention is recommended at the onset of symptoms or in the presence of left ventricular systolic impairment. Whether surgery is appropriate for asymptomatic patients remains a controversial issue. We argue the case for early pre-emptive intervention in selected, asymptomatic individuals with AS or MR, drawing on contemporary perioperative data, predictors of disease progression, and studies of the natural history of degenerative valvular heart disease.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Maganti, K., Rigolin, V. H., Sarano, M. E. & Bonow, R. O. Valvular heart disease: diagnosis and management. Mayo Clin. Proc. 85, 483–500 (2010).
Goldbarg, S. H., Elmariah, S., Miller, M. A. & Fuster, V. Insights into degenerative aortic valve disease. J. Am. Coll. Cardiol. 50, 1205–1213 (2007).
Iung, B. et al. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease. Eur. Heart J. 24, 1231–1243 (2003).
Bonow, R. O. et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 114, e84–e231 (2006).
Vahanian, A. et al. Guidelines on the management of valvular heart disease: the Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur. Heart J. 28, 230–268 (2007).
Rosenhek, R. et al. Predictors of outcome in severe, asymptomatic aortic stenosis. N. Engl. J. Med. 343, 611–617 (2000).
Pellikka, P. A. et al. Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up. Circulation 111, 3290–3295 (2005).
Rosenhek, R. et al. Natural history of very severe aortic stenosis. Circulation 121, 151–156 (2010).
Malaisrie, S. C. et al. Contemporary perioperative results of isolated aortic valve replacement for aortic stenosis. Ann. Thorac. Surg. 89, 751–756 (2010).
Kang, D. H. et al. Early surgery versus conventional treatment in asymptomatic very severe aortic stenosis. Circulation 121, 1502–1509 (2010).
Tribouilloy, C. M. et al. Impact of preoperative symptoms on survival after surgical correction of organic mitral regurgitation: rationale for optimizing surgical indications. Circulation 99, 400–405 (1999).
David, T. E., Ivanov, J., Armstrong, S. & Rakowski, H. Late outcomes of mitral valve repair for floppy valves: implications for asymptomatic patients. J. Thorac. Cardiovasc. Surg. 125, 1143–1152 (2003).
Enriquez-Sarano, M. & Sundt, T. M. 3rd. Early surgery is recommended for mitral regurgitation. Circulation 121, 804–811 (2010).
Goodney, P. P., O'Connor, G. T., Wennberg, D. E. & Birkmeyer, J. D. Do hospitals with low mortality rates in coronary artery bypass also perform well in valve replacement? Ann. Thorac. Surg. 76, 1131–1136 (2003).
Grigioni, F. et al. Atrial fibrillation complicating the course of degenerative mitral regurgitation: determinants and long-term outcome. J. Am. Coll. Cardiol. 40, 84–92 (2002).
Picano, E., Pibarot, P., Lancellotti, P., Monin, J. L. & Bonow, R. O. The emerging role of exercise testing and stress echocardiography in valvular heart disease. J. Am. Coll. Cardiol. 54, 2251–2260 (2009).
Das, P., Rimington, H. & Chamber, J. Exercise testing to stratify risk in aortic stenosis. Eur. Heart J. 26, 1309–1313 (2005).
Bergler-Klein, J. et al. Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis. Circulation 109, 2302–2308 (2004).
Pizarro, R. et al. Prospective validation of the prognostic usefulness of brain natriuretic peptide in asymptomatic patients with chronic severe mitral regurgitation. J. Am. Coll. Cardiol. 54, 1099–1106 (2009).
Messika-Zeitoun, D. et al. Cardiopulmonary exercise testing determination of functional capacity in mitral regurgitation: physiologic and outcome implications. J. Am. Coll. Cardiol. 47, 2521–2527 (2006).
Edwards, F. H. et al. Prediction of operative mortality after valve replacement surgery. J. Am. Coll. Cardiol. 37, 885–892 (2001).
Ambler, G. et al. Generic, simple risk stratification model for heart valve surgery. Circulation 112, 224–231 (2005).
Enriquez-Sarano, M. et al. Quantitative determinants of the outcome of asymptomatic mitral regurgitation. N. Engl. J. Med. 352, 875–883 (2005).
Rosenhek, R. et al. Outcome of watchful waiting in asymptomatic severe mitral regurgitation. Circulation 113, 2238–2244 (2006).
Enriquez-Sarano, M. et al. Echocardiographic prediction of survival after surgical correction of organic mitral regurgitation. Circulation 90, 830–837 (1994).
Shuhaiber, J. & Anderson, R. J. Meta-analysis of clinical outcomes following surgical mitral valve repair or replacement. Eur. J. Cardiothorac. Surg. 31, 267–275 (2003).
Enriquez-Sarano, M. et al. Valve repair improves the outcome of surgery for mitral regurgitation. A multivariate analysis. Circulation 91, 1022–1028 (1995).
Adams, D. H. et al. Large annuloplasty rings facilitate mitral valve repair in Barlow's disease. Ann. Thorac. Surg. 82, 2096–2100 (2006).
Kang, D. H. et al. Comparison of early surgery versus conventional treatment in asymptomatic severe mitral regurgitation. Circulation 119, 797–804 (2009).
Gammie, J. S., O'Brien, S. M., Griffith, B. P., Ferguson, T. M. & Peterson, E. D. Influence of hospital procedural volume on care process and mortality for patients undergoing elective surgery for mitral regurgitation. Circulation 115, 881–887 (2007).
Author information
Authors and Affiliations
Contributions
P. Vaishnava researched the data for the article, contributed substantially to the discussion of content, wrote the article, and reviewed and edited the manuscript before submission and after peer-review. V. Fuster, M. Goldman, and R. O. Bonow provided substantial contributions to the discussion of the content and to review and editing of the manuscript before submission and after peer-review.
Corresponding author
Ethics declarations
Competing interests
R. O. Bonow is a consultant on transcatheter valve technologies for Edwards LifeSciences. The other authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Vaishnava, P., Fuster, V., Goldman, M. et al. Surgery for asymptomatic degenerative aortic and mitral valve disease. Nat Rev Cardiol 8, 173–177 (2011). https://doi.org/10.1038/nrcardio.2010.203
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrcardio.2010.203
This article is cited by
-
Mutations in DCHS1 cause mitral valve prolapse
Nature (2015)
-
Timing of Aortic Valve Intervention in Pediatric Chronic Aortic Insufficiency
Pediatric Cardiology (2014)
-
Is comorbidity equivalent to symptoms in asymptomatic AS?
Nature Reviews Cardiology (2011)
-
Comorbidity in patients with asymptomatic AS
Nature Reviews Cardiology (2011)